Key result
Lower DPA/AA ratio strongly predicts primary aldosteronism in young and middle-aged adults.
Why the study?
Diagnosis of primary aldosteronism in young and middle-aged adults remains challenging due to low screening rates and complex testing procedures.
Does the serum DPA/AA ratio improve the diagnostic prediction of primary aldosteronism in young and middle-aged adults with hypertension?
Case-Control (n=276)
No
Does the serum DPA/AA ratio improve the diagnostic prediction of primary aldosteronism in young and middle-aged adults with hypertension?
Effect estimate: OR 0.001 (95% CI 0.000-0.001)
Absolute Event Rate: 0.06% vs 0.08%
p-value: p=<0.001
The serum DPA/AA ratio is a strong, independent inverse biomarker for primary aldosteronism that significantly improves diagnostic accuracy when added to traditional clinical models in young and middle-aged adults.
May improve PA diagnostic models in young/middle-aged hypertensives; extends evidence as strong independent biomarker but requires prospective validation before adoption.
Background Primary aldosteronism (PA) is a common cause of secondary hypertension, yet its diagnosis in young and middle-aged adults remains challenging due to low screening rates and complex testing procedures. Objective This study aimed to investigate serum polyunsaturated fatty acid (PUFA) profiles, particularly the docosapentaenoic acid/arachidonic acid (DPA/AA) ratio, as novel biomarkers of PA in young adults. Methods This 1:1 matched case–control study was performed on 138 young and middle-aged patients with PA and 138 essential hypertension (EH) controls. Serum PUFA levels were measured, and their associations with PA were analyzed using univariate and multivariate logistic regression analyses. Using bootstrap to conduct internal validation. The receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) were employed to evaluate both the predictive performance and clinical practicability of the model. Results Young and middle-aged patients with PA exhibited a distinct phenotype, including more severe hypertension, higher fasting blood glucose level, elevated low-density lipoprotein-cholesterol level, lower platelet count, and greater burden of left ventricular hypertrophy and albuminuria. A significantly reduced DPA/AA ratio was the most notable finding in the PA group. The multivariate analysis revealed DPA/AA as a strong independent inverse predictor of PA. Adding DPA/AA to a baseline model of traditional clinical and biochemical variables increased the area under the curve (AUC) from 0.849 to 0.866. The integration into a more comprehensive model also improved the AUC from 0.872 to 0.887. Conclusions The DPA/AA ratio is a robust, independent biomarker of PA in young and middle-aged adults. Its incorporation into diagnostic models significantly enhances predictive accuracy, thus offering a promising noninvasive approach to improve early detection in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) conducted a case-control in Primary Aldosteronism (n=276). DPA/AA ratio vs. Essential Hypertension (EH) group was evaluated on DPA/AA ratio as a biomarker for primary aldosteronism (OR 0.001, 95% CI 0.000-0.001, p=<0.001). The DPA/AA ratio significantly predicted primary aldosteronism with an odds ratio of 0.001, indicating a strong inverse association in young and middle-aged adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: